Regeneron Study Site
Little Rock, Arkansas
We've found
2 trials
at this facility
Atopic Dermatitis Clinical Trial
Updated: 1/4/2016
Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
Status: Enrolling,
Phase
I
Updated: 1/4/2016
Click here to add this to my saved trials
Eosinophilic Esophagitis Clinical Trial
Updated: 12/31/1969
Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials